?1 Receptor Agonist - Globe Thesis

Keyword [?1 Receptor Agonist] Result: 41 - 60 \| Page: 3 of 4
41.	Clinical Study On GLP-1RA Treatment Of Early Renal Injury In Obese Type 2 Diabetes Mellitus
42.	Effect Of Glucagon-like Peptide-1 Receptor Agonist On Carotid Atherosclerosis In Patients With Type 2 Diabetes Mellitus
43.	Efficacy And Safety Of Once-weekly GLP-1RA Versus Daily GLP-1RA For Type 2 Diabetes Mellitus:A Meta-analysis
44.	The Effect And Mechanisms Of Long-acting GLP-1 Receptor Agonist Semaglutide On Phenotypic Transition Of Microglia And Neuroinflammation On Epileptogenesis In The Rat After Status Epilepticus
45.	The Effect And Mechanisms Of Long-acting GLP-1 Receptor Agonist Semaglutide On Phenotypic Transition Of Microglia And Neuroinflammation After Cerebral Ischemia/Reperfusion In Rats
46.	Effects Of GLP-1RA On Rats With Type 2 Diabetes Mellitus And Nonalcoholic Fatty Liver Disease
47.	A Meta-Analysis Of The Efficacy And Safety Of Subcutaneous Injection Of Exenatide Once Weekly In The Treatment Of Type 2 Diabetes Mellitus
48.	Efficacy And Safety Of GLP-1 Receptor Agonists Versus DPP-4 Inhibitors In The Treatment Of Type 2 Diabetes Mellitus:A Meta-analysis
49.	Study On The Preparation Process Of Semaglutide Based On A Novel Hydrophobic-Supports-Assisted Liquid-phase Peptide Synthetic Method
50.	Evaluation Of The Effectiveness And Economics Of DPP-4 Inhibitors And GLP-1 Receptor Agonists In The Treatment Of Type 2 Diabetes
51.	The Metabolic Profile Of Overweight/obese Type 2 Diabetic Patients And The Effect Of Glucagon-like Peptide-1 Receptor Agonist On Patients' Metabolic Indicators
52.	GLP-1 Receptor Agonist Exendin-4 Improves Glycemic Control Through Beta Cell and Non-beta Cell Mechanism
53.	The Role Of Pink1/Parkin-mediated Mitophagy In Insulin Resistance-induced Neuronal Damage
54.	Meta-analysis Of The Efficacy Of GLP-1 Receptor Agonist Liraglutide In The Treatment Of Patients With Type 2 Diabetes Combined With Non-alcoholic Fatty Liver Disease
55.	A Meta-analysis Of Glucagon-like Peptide-1 Receptor Agonists In Adults With Non-alcoholic Fatty Liver Disease
56.	A Network Meta-analysis Of SGLT-2 Inhibitors,GLP-1receptor Agonists And DPP-4 Inhibitors For Improving NAFLD
57.	Glucagon-like Peptide-1 Receptor Agonists And Pancreatitis And/or Pancreatic Cancer Risk In T2DM:a Systemic Review And Meta-analysis
58.	The Study About Effect And Mechanism Of Liraglutide And Dapagliflozin On Cardiac Function In Type 2 Diabetic Patients
59.	Systematic Evaluation Of Renal Protection Of Liraglutide In Diabetic Patients
60.	Gut Microbiota Mediates The Improvement Of Body Weight In Simple Obese Mice With GLP-1 Receptor Agonist
<<First <Prev Next> Last>> Jump to